Skip to Content


In the US, Vemurafenib (vemurafenib systemic) is a member of the drug class multikinase inhibitors and is used to treat Erdheim-Chester Disease and Melanoma - Metastatic.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent

Tyrosine kinase inhibitor

Chemical Names

N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-carbonyl]-2,4,-difluorophenyl}propane-1-sulfonamide (WHO)

Propane-1-sulfonic acid {3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide

Foreign Names

  • Vemurafenibum (Latin)
  • Vemurafenib (German)
  • Vemuraf√©nib (French)
  • Vemurafenib (Spanish)

Generic Names

  • Vemurafenib (OS: USAN, BAN)
  • PLX 4032 (IS)
  • RG 7204 (IS)
  • RO 5185426 (IS)
  • UNII-207SMY3FQT (IS)

Brand Names

  • Zelboraf
    Dr. F. Hoffmann-Lja - Roche, Russian Federation; Genentech, United States; Haemato Pharm, Austria; Hoffmann-La Roche, Bosnia & Herzegowina; Orifarm, Norway; Productos Roche, Chile; Roche, Australia; Roche, Belgium; Roche, Canada; Roche, Colombia; Roche, Germany; Roche, Denmark; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Lithuania; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Poland; Roche, Romania; Roche, Sweden; Roche, Thailand; Roche Products, United Kingdom; Roche Registration, Austria


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.